Glycomine completes enrollment in Phase 2b trial for rare genetic disorder
The study is a global, randomized, double-blind, placebo-controlled trial testing GLM101 for phosphomannomutase 2 congenital disorder of glycosylation
The study is a global, randomized, double-blind, placebo-controlled trial testing GLM101 for phosphomannomutase 2 congenital disorder of glycosylation
Three-day programme equips CSIR researchers with advanced AI tools, molecular docking insights, and biomolecular simulation expertise
A major highlight of the event was the launch of several publications and digital initiatives, including a certification course on the Ayush Grid portal
The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE
The device aims to bring precision neuroscience into clinical trials, accelerating drug development
The initiative is aimed at strengthening the district-level screening and chronic disease management infrastructure
Experts also underscored the growing role of technologies such as tele-neurorehabilitation, robotics, and AI-driven therapies in improving recovery outcomes
Former Global Head of IT & Digital Transformation at Biocon Biologics steps into enterprise-wide technology leadership role
In his new role, he is expected to further strengthen Zenex Animal Health’s market position and accelerate its next phase of growth.
The leading hospital chain appoints Lokesh Taridalu Shivakumar as Facility Director for Yeshwanthapur hospital
Subscribe To Our Newsletter & Stay Updated